Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 14 | 2023 | 3047 | 1.880 |
Why?
|
| Pulmonary Emphysema | 8 | 2021 | 672 | 1.800 |
Why?
|
| Thorax | 2 | 2023 | 547 | 0.770 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2019 | 1155 | 0.710 |
Why?
|
| Lung | 9 | 2023 | 9856 | 0.630 |
Why?
|
| Pulmonary Artery | 2 | 2021 | 1912 | 0.610 |
Why?
|
| P-Selectin | 1 | 2019 | 600 | 0.580 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2019 | 707 | 0.580 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2022 | 20129 | 0.510 |
Why?
|
| Emphysema | 1 | 2017 | 247 | 0.500 |
Why?
|
| Air Pollution | 4 | 2019 | 2286 | 0.500 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2017 | 924 | 0.490 |
Why?
|
| Auditory Perception | 1 | 2019 | 569 | 0.480 |
Why?
|
| Respiratory Function Tests | 5 | 2021 | 1616 | 0.410 |
Why?
|
| Atherosclerosis | 3 | 2019 | 3445 | 0.390 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2019 | 808 | 0.390 |
Why?
|
| Cardiovascular Agents | 1 | 2017 | 850 | 0.390 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 1518 | 0.360 |
Why?
|
| Air Pollutants | 3 | 2019 | 2817 | 0.360 |
Why?
|
| Spirometry | 4 | 2023 | 864 | 0.360 |
Why?
|
| Pulmonary Heart Disease | 1 | 2019 | 36 | 0.350 |
Why?
|
| Particulate Matter | 4 | 2019 | 2530 | 0.350 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 4456 | 0.320 |
Why?
|
| Vital Capacity | 3 | 2019 | 925 | 0.250 |
Why?
|
| Heart Ventricles | 4 | 2020 | 3821 | 0.250 |
Why?
|
| Disease Progression | 7 | 2021 | 13284 | 0.220 |
Why?
|
| Bronchiectasis | 1 | 2023 | 128 | 0.210 |
Why?
|
| E-Selectin | 1 | 2014 | 579 | 0.210 |
Why?
|
| Aspirin | 2 | 2018 | 3282 | 0.200 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2019 | 944 | 0.190 |
Why?
|
| Asthma | 1 | 2019 | 6011 | 0.180 |
Why?
|
| Auscultation | 1 | 2019 | 42 | 0.170 |
Why?
|
| Nitrogen Oxides | 2 | 2019 | 129 | 0.170 |
Why?
|
| Environmental Exposure | 3 | 2019 | 4234 | 0.160 |
Why?
|
| Thrombocytosis | 1 | 2018 | 81 | 0.150 |
Why?
|
| Health Status Disparities | 1 | 2019 | 1797 | 0.150 |
Why?
|
| Angiotensins | 1 | 2017 | 151 | 0.150 |
Why?
|
| Ventricular Function, Right | 1 | 2010 | 591 | 0.140 |
Why?
|
| Linear Models | 4 | 2019 | 5952 | 0.140 |
Why?
|
| Aged, 80 and over | 9 | 2019 | 57776 | 0.140 |
Why?
|
| Ozone | 2 | 2019 | 469 | 0.140 |
Why?
|
| Middle Aged | 18 | 2023 | 213383 | 0.140 |
Why?
|
| Forced Expiratory Volume | 3 | 2023 | 1743 | 0.130 |
Why?
|
| Tomography | 1 | 2017 | 390 | 0.130 |
Why?
|
| Carbon | 2 | 2019 | 687 | 0.130 |
Why?
|
| Longitudinal Studies | 3 | 2021 | 13989 | 0.120 |
Why?
|
| Aged | 14 | 2021 | 163280 | 0.120 |
Why?
|
| Sleep | 1 | 2019 | 4623 | 0.110 |
Why?
|
| Humans | 25 | 2023 | 744343 | 0.110 |
Why?
|
| Exercise | 2 | 2016 | 5615 | 0.110 |
Why?
|
| Male | 17 | 2023 | 350118 | 0.100 |
Why?
|
| Smoking | 4 | 2023 | 8987 | 0.100 |
Why?
|
| Prospective Studies | 7 | 2023 | 53288 | 0.100 |
Why?
|
| Female | 18 | 2023 | 380194 | 0.100 |
Why?
|
| Organ Size | 2 | 2019 | 2252 | 0.090 |
Why?
|
| United States | 8 | 2021 | 69872 | 0.090 |
Why?
|
| Motor Activity | 1 | 2010 | 2714 | 0.090 |
Why?
|
| Exercise Tolerance | 2 | 2019 | 770 | 0.090 |
Why?
|
| Dyspnea | 1 | 2017 | 1303 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2023 | 3507 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2017 | 6459 | 0.070 |
Why?
|
| Respiratory System | 1 | 2019 | 557 | 0.070 |
Why?
|
| Cohort Studies | 5 | 2023 | 40561 | 0.070 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2017 | 371 | 0.070 |
Why?
|
| Genotype | 1 | 2019 | 12951 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 12245 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15540 | 0.060 |
Why?
|
| Actigraphy | 1 | 2016 | 488 | 0.060 |
Why?
|
| Polysomnography | 1 | 2019 | 1776 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2022 | 12354 | 0.050 |
Why?
|
| Parasympathectomy | 1 | 2020 | 3 | 0.050 |
Why?
|
| Mucociliary Clearance | 1 | 2020 | 67 | 0.050 |
Why?
|
| Molecular Epidemiology | 1 | 2022 | 468 | 0.050 |
Why?
|
| Incidence | 2 | 2019 | 20947 | 0.040 |
Why?
|
| Hospitalization | 1 | 2019 | 10262 | 0.040 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2020 | 107 | 0.040 |
Why?
|
| Inflammation | 1 | 2019 | 10638 | 0.040 |
Why?
|
| Endophenotypes | 1 | 2020 | 250 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2020 | 407 | 0.040 |
Why?
|
| Mortality | 1 | 2019 | 2864 | 0.040 |
Why?
|
| Complement System Proteins | 1 | 2020 | 795 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 427 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39050 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 687 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2020 | 721 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2016 | 2073 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10943 | 0.030 |
Why?
|
| Disease | 1 | 2020 | 680 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2016 | 5007 | 0.030 |
Why?
|
| Air Pollution, Indoor | 1 | 2020 | 857 | 0.030 |
Why?
|
| Adult | 3 | 2023 | 214055 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2020 | 7181 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 2214 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2020 | 1632 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2107 | 0.020 |
Why?
|
| Pneumonia | 1 | 2020 | 2133 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2020 | 2958 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3690 | 0.020 |
Why?
|
| Neutrophils | 1 | 2020 | 3719 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 29063 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 6487 | 0.020 |
Why?
|
| Sex Factors | 1 | 2020 | 10397 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 3068 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 7913 | 0.020 |
Why?
|
| Comorbidity | 1 | 2018 | 10388 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 35421 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 77449 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 15165 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17446 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 25043 | 0.010 |
Why?
|
Concepts
(110)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_